Annexin Pharmaceuticals AB (publ)
ANNX SE0009664154
ICB 2010 : Health Care / Health CareAnnual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 553% | 409% | 359% | 1807% | 7% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Mikael Lönn DIR |
0.25 SEK |
560,000 Bought |
140,000 SEK |
03/07/2024 | 03/07/2024 |
| Nils Anders Haegerstrand CEO |
0.25 SEK |
145,600 Bought |
36,400 SEK |
03/07/2024 | 03/07/2024 |
| Uli Hacksell CB |
0.87 SEK |
100,000 Bought |
86,900 SEK |
17/03/2022 | 15/03/2022 |
| Carl-fredrik Lindner CB |
1.80 SEK |
40,688 Bought |
73,238 SEK |
24/12/2020 | 23/12/2020 |
| Carl-fredrik Lindner CB |
1.77 SEK |
2,000 Bought |
3,540 SEK |
24/12/2020 | 23/12/2020 |
| Carl-fredrik Lindner CB |
1.78 SEK |
3,000 Bought |
5,340 SEK |
24/12/2020 | 23/12/2020 |
| Carl-fredrik Lindner CB |
1.78 SEK |
29,998 Bought |
53,396 SEK |
24/12/2020 | 23/12/2020 |
| Carl-fredrik Lindner CB |
1.80 SEK |
2,145 Bought |
3,850 SEK |
24/12/2020 | 23/12/2020 |
| Carl-fredrik Lindner CB |
1.78 SEK |
2,169 Bought |
3,850 SEK |
24/12/2020 | 23/12/2020 |
| Jamal El Mosleh CEO |
1.59 SEK |
38,452 Bought |
61,139 SEK |
11/03/2019 | 11/03/2019 |